Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS)

Menopause

Volumn 13, Issue 1, 2006, Pages 46-56

  Leiblum, Sandra R ^a   Koochaki, Patricia E ^b   Rodenberg, Cynthia A ^b   Barton, Ian P ^b   Rosen, Raymond C ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Female sexuality; Hypoactive sexual desire disorder; Postmenopausal; Women's International Study of Health and Sexuality

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SEXUAL DYSFUNCTION; SEXUAL SATISFACTION; COMPARATIVE STUDY; HEALTH STATUS; HEALTH SURVEY; LIBIDO; MENTAL STRESS; MIDDLE AGED; OVARIECTOMY; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; SEXUALITY; UNITED STATES; WOMEN'S HEALTH;

ADULT; AGED; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; LIBIDO; MIDDLE AGED; OVARIECTOMY; POSTMENOPAUSE; QUESTIONNAIRES; SEXUAL PARTNERS; SEXUALITY; STRESS, PSYCHOLOGICAL; UNITED STATES; WOMEN'S HEALTH;

EID: 33645985505     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gme.0000172596.76272.06     Document Type: Article

References (35)

1. Hallstrom T. Sexuality in the climacteric. Clin Obstet Gynaecol 1977;4:227-239.
2. Osborn M, Hawton K, Gath D. Sexual dysfunction among middle aged women in the community. BMJ (Clin Res Ed) 1988;296:959-962.
3. Hallstrom T, Samuelsson S. Changes in women's sexual desire in middle life: the longitudinal study of women in Gothenburg. Arch Sex Behav 1990;19:259-268.
4. Bancroft J, Cawood EH. Androgens and the menopause: a study of 40-60-year-old women. Clin Endocrinol (Oxf) 1996;45:577-587.
5. Avis NE, Stellato R, Crawford S, Johannes C, Longcope C. Is there an association between menopause status and sexual functioning? Menopause 2000;7:297-309.
6. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001;76:456-460.
7. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002;77(Suppl 4):S42-S48.
8. Dennerstein L, Smith AM, Morese CA, Burger HG. Sexuality and the menopause. J Psychosom Obstet Gynaecol 1994;15:59-66.
9. Nathorst-Boos J, von Schoultz B, Carlstrom K. Elective ovarian removal and estrogen replacement therapy: effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 1993;14:283-293.
10. Mazer NA. Testosterone deficiency in women: etiologies, diagnosis, and emerging treatments. Int J Fertil Womens Med 2002;47:77-86.
11. Kuppermann M, Varner RE, Summitt RL Jr, et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA 2004;291:1447-1455.
12. Rhodes JC, Kjerulff KH, Langenberg PW, Guzinski GM. Hysterectomy and sexual functioning. JAMA 1999;282:1934-1941.
13. Kritz-Silverstein D, Von Muhlen DG, Ganiats TG, Barrett-Connor E. Hysterectomy status, estrogen use, and quality of life in older women: the Rancho Bernardo study. Qual Life Res 2004;1:55-62.
14. American Psychiatric Association. DSM-IV-TR Diagnostic and Statistical Classification Manual for Mental Disorders, 4th ed. Washington, DC: American Psychiatric Press, 2000.
15. Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163:888-893.
16. Basson R, Leiblum S, Brotto L, et al. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychosom Obstet Gynaecol 2003;24:221-229.
17. Bancroft J, Loftus J, Long JS. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav 2003;32:193-208.
18. Hart G, Wellings K. Sexual behaviour and its medicalisation: in sickness and in health. BMJ 2002;324:896-900.
19. Moynihan R. The making of a disease: female sexual dysfunction. BMJ 2003;326:45-47.
20. Ware JE, Sherbourne CD. The MOS 36-item Short Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
21. McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short Form Health Survey (SF-36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs. Med Care 1993;31:247-263.
22. Ware JE, Snow KK, Kosinski M, Gandek M. SF-36 Health Survey Manual and Interpretation Guide. Boston: New England Medical Center, The Health Institute, 1993.
23. McHorney CA, Rust J, Golombok S, Davis S, Bouchard C, Brown C. Profile of Female Sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause 2004;11:474-483.
24. Derogatis LR, Rust J, Golombok S. Validation of the profile of female sexual function (PFSF) in surgically and naturally menopausal women. J Sex Marital Ther 2004;30:25-36.
25. Derogatis L, Rust J, Golombok S, Kuznicki J, Rodenberg C, McHorney C. A patient-generated, multinational inventory to measure distress associated with low desire. Abstract presented at: the Annual Meeting of the International Society for the Study of Women's Sexual Health, October 28-31; 2004; Atlanta, GA.
26. Braunstein G. Safety and efficacy of transdermal testosterone therapy versus placebo in surgically menopausal women receiving oral estrogen. Abstract presented at: the Annual Meeting of The North American Menopause Society; September 17-20, 2003; Miami Beach, FL.
27. Davis S, Rees M, Ribot C, Moufarege A, Rodenberg C, Purdie D. Efficacy and safety of testosterone patches for the treatment of low sexual desire in surgically menopausal women. Fertil Steril 2003;80(Suppl 3):S76.
28. Simon JA, Nachtigall L, Davis S, Utian W, Lucas J, Braunstein G. Transdermal testosterone patch improves sexual activity and desire in surgically menopausal women. Obstet Gynecol 2004;103(Suppl):64S.
29. Buster J, Kingsberg S, Aguirre O, Brown C, Wekselman K, Casson P. Large phase III study confirms that transdermal testosterone patch 300 μg/day significantly improves sexual function with minimal side effects in surgically menopausal women. Abstract presented at: the Annual Meeting of the Endocrine Society Meeting; June 16-19, 2004; New Orleans, LA.
30. Metz CE. Basic principles of ROC analysis. Semin Nucl Med 1978;8:283-298.
31. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-544.
32. Fugl-Meyer A, Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74 year old Swedes. Scand J Sexol 1999;2:79-105.
33. Basson R. Using a different model for female sexual response to address women's problematic low desire. J Sex Marital Ther 2001;5:395-403.
34. Basson R. Rethinking low sexual desire in women. BJOG 2002;4:357-363.
35. Judd HL, Judd GE, Lucas WE, Yen SS. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J Clin Endocrinol Metab 1974;39:1020-1024.